Tradestie Institutional Equity Comparison Engine
FEMY vs ICU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FEMY Overall Edge
FEMY Captures Institutional Edge (2โ1 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Femasys Inc. Common Stock (FEMY) driven by superior Momentum & Technical, Options & Structure while ICU counters with relative strength in Growth & Margin. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus ICU at N/M Forward P/E and -816.6% operating margin (+82.0% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ICU sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FEMY N/M vs ICU N/M Fwd P/E
Growth & Margin Winner
ICU
Op Margin -763.9% vs -816.6% ยท YoY -18.9% vs +82.0%
Momentum & Technical Winner
FEMY
1Y +54.8% vs +85.5% ยท 52W Pos 17% vs 12%
Options & Structure Winner
FEMY
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
FEMY
NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap
$11.9M
1M Return
-22.42%
1Y Return
+54.78%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 61.0
Fund 62.0
Flow 50.0
Mom 64.0
ICU
NASDAQ
SeaStar Medical Holding Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.85
+1.8% 1D
Market Cap
$4.5M
1M Return
-70.57%
1Y Return
+85.5%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FEMY +54.78%
ICU +85.5%
Spread: +30.72 pp (ICU Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | FEMY Revenue | ICU Revenue | FEMY Op. Margin | ICU Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $0M | N/A | -668.0% | N/A | FEMY |
| FY2021 | $0M | N/A | -706.7% | N/A | FEMY |
| FY2022 | $0M | N/A | -961.7% | N/A | FEMY |
| FY2023 | $0M | N/A | -1353.4% | N/A | FEMY |
| FY2024 | $0M | $0M | -1091.8% | -13216.3% | FEMY |
| FY2025 | $0M | $0M | -767.0% | -986.6% | FEMY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FEMY | ICU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $11.9M | $4.5M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -18.9% | +82.0% | Higher Growth | ICU |
| Operating Margin (TTM) Profitability | -763.9% | -816.6% | Higher Margin | FEMY |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -425.0% | -356.9% | Higher ROE | ICU |
| 52-Week Range Position Momentum | 17% ($0โ$6) | 12% ($0โ$5) | Stronger Trend | FEMY |
| Beta / 30D Volatility Risk Regime | 4.01ฮฒ ยท 72% Vol | 1.35ฮฒ ยท 174% Vol | Lower Realized Risk | FEMY |
| Unified Institutional Score Composite Signal | 52.6 / 100 (HOLD) | 41.7 / 100 (SELL) | Higher Composite | FEMY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FEMY vs ICU Buy Guide
FEMY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ICU
BREAKDOWN
133d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FEMY nor ICU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.